Genetic analysis of the α2-macroglobulin gene in early- and late-onset Parkinson's disease

NeuroReport

Volumn 11, Issue 11, 2000, Pages 2439-2442

  Krüger, Rejko ^a   Menezes Saecker, Ana M V ^a   Schöls, Ludger ^a   Kuhn, Wilfried ^a   Müller, Thomas ^a   Woitalla, Dirk ^a   Berg, Daniela ^b   Berger, Klaus ^b   Przuntek, Horst ^a   Epplen, Jörg T ^a   Riess, Olaf ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NONE

Author keywords

Age at disease onset; Genetics; Parkinson's disease; 2 Macroglobulin

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC RISK; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; GENETICS; GENOTYPE;

AGE OF ONSET; AGED; ALLELES; ALPHA-MACROGLOBULINS; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; FEMALE; GENE DELETION; GENOTYPE; HUMANS; MALE; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 0034601312     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200008030-00020     Document Type: Article

References (28)

1. 1. Glenner GG and Wong CW. Biochem Biophys Res Commun 1, 885-890 (1984).
2. 2. Arai H, Lee VM, Hill WD et al. Brain Res 585, 386-390 (1992).
3. 3. Spillantini MG, Schmidt ML, Lee VM et al. Nature 388, 839-840 (1997).
4. 4. Ueda K, Fukushima H, Masliah E et al. Proc Natl Acad Sci USA 90, 11282-11286 (1993).
5. 5. Polymeropoulos MH, Laavedan C, Leroy E et al. Science 276, 2045-2047 (1997).
6. 6. Krüger R, Kuhn W, Müller Th et al. Nature Genet 18, 106-108 (1998).
7. 7. Xia Y, Rohan de Silva HA, Rosi BL et al. Ann Neurol 40, 207-15 (1996).
8. 8. Krüger R, Kuhn W, Müller T et al. Ann Neurol 45, 611-617 (1999).
9. 9. Pollanen MS, Dickson DW and Bergeron C. J Neuropathol Exp Neurol 52, 183-191 (1993).
10. 10. Rebeck WG, Harr SD, Strickland DK et al. Ann Neurol 37, 211-217 (1995).
11. 11. Du Y, Bales KR, Dodel RC et al. J Neurochem 70, 1182-1188 (1998).
12. 12. Hughes SR, Khorkova O, Goyal S et al. Proc Natl Acad Sci USA 95, 3275-3280 (1998).
13. 13. Poller W, Faber JP, Klobeck et al. Hum Genet 88, 313-319 (1992).
14. 14. Matthijs G and Marynen P. Nucl Acids Res 19, 5102 (1990).
15. 15. Blacker D, Wilcox MA, Laird NM et al. Nat Genet 19,357-360 (1998).
16. 16. Liao A, Nitsch RM, Greenber SM et al. Hum Mol Genet 7, 1953-1956 (1998).
17. 17. Alvarez V, Alvarez R, Lahoz CH et al. Biochem Biohphys Res Commun 264, 48-50 (1999).
18. 18. Dodel RC, Du Y, Bales KR et al. Neurology 54, 438-442 (2000).
19. 19. Gibb WRG and Lees AJ. J Neurol Neurosurg Psychiatry 51, 745-752 (1998).
20. 20. Rothdach AJ, Trenkwalder C, Haberstock J et al. Neurology 54, 1064-1068 (2000).
21. 21. Hense HW, Stieber J, Filipiak B et al. Ann Epidemiol 3, 410-416 (1993).
22. 22. Fahn S, Elton R, Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB and Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information; 1987, pp. 153-163.
23. 23. Svejgard A and Ryder LP. Tissue Antigens 43, 18-27 (1994).
24. 24. Gamier-Gere P and Dillmann C. J Heredity 83, 239 (1992).
25. 25. Singleton AB, Gibson AM, McKeith IG et al. Neuroreport 10, 1507-1510 (1999).
26. 26. Rogaeva EA, Premkumar S, Grubber J et al. Nature Genet 22, 19-21 (1999).
27. 27. Zareparsi S, Kaye J, Camicioli R et al. Ann Neurol 42, 655-658 (1997).
28. 28. Bon MA, Jansen Steur EN, de Vos RA et al. Neurosci Lett 266, 149-151 (1999).